Expert Advisory Group

The Expert Advisory Group was established in 2011 to evaluate HIV licensing agreements and provide suggestions for improvements, to ensure greater access to priority medicines in developing countries. We expanded the EAG in October 2016, to include eleven new members with hepatitis C and tuberculosis expertise. The newly constituted EAG now operates in three sub-groups, each focusing on one of our disease areas: HIV, hepatitis C and tuberculosis. Kees de Joncheere, most recently Director of the Essential Medicines and Health Products Department at the World Health Organization (WHO), serves as the EAG’s Vice Chair. The EAG is currently chaired by Maximiliano Santa Cruz of Chile.

The EAG reports on the MPP licences are publicly available as stated in our transparency policy.

 

Access the EAG Terms of Reference

Chair
Maximiliano Santa Cruz (National Institute of Industrial Property, Chile)
Vice Chair
Kees de Joncheere (Former Director of the Essential Medicines and Health Products Department, WHO, Switzerland)

HIV Subgroup

Johannesburg Bar, South Africa
Jonathan Berger
Hopitaux Universitaires de Genève, Switzerland
Alexandra Calmy
National Empowerment Network of People Living with HIV/AIDS (NEPHAK), Kenya
Nelson Juma Otwoma
Shuttleworth Foundation Fellow, India
Achal Prabhala
Bolivian Network of Positive People, Bolivia
Gracia Violeta Ross
Center for Interdisciplinary Studies, University of Buenos Aires, Argentina
Carlos Correa
World Health Organization, Switzerland
Nathan Ford

Hepatitis C/Viral Hepatitis Subgroup

Medicines Law & Policy/Global Health Unit University Medical Centre Groningen, The Netherlands
Ellen't Hoen
International AIDS Vaccine Initiative, USA
Labeeb Abboud
World Health Organization, Switzerland
Philippa Easterbrook
The World Hepatitis Alliance, United Kingdom
Raquel Peck
Médecins Sans Frontières (MSF), Switzerland
Isabelle Andrieux-Meyer
Saint-Antoine Hospital (AP-HP), France
Karine Lacombe
AmfAR’s TREAT Asia Programme, Thailand
Giten Khwairakpam

Tuberculosis/Antimicrobial Resistance Subgroup

Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), USA
Jennifer Cohn
Bill & Melinda Gates Foundation, USA
Jan Gheuens
Communication for Development Centre, Nigeria
Mayowa Joel
World Health Organization, Switzerland
Christian Lienhardt
World Intellectual Property Organization, Republic of Korea
Eun-Joo Min
HIV and TB Treatment Advocate, South Africa
Wim Vandevelde